Device manufacturer, as written on reports
Medtronic Puerto Rico Operations Med-Rel: medical device reports filed with FDA
10,804 reports name it as the manufacturer of the device involved, 2006–2011.
- 10,804
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 37.5%
- classified as malfunction
- 62.3% across all reports
- 2.2%
- classified as death, as reported
- 0.9% across all reports
10,804 medical device reports received by FDA give Medtronic Puerto Rico Operations Med-Rel as the manufacturer of the device involved, 0% of the MAUDE database, from June 2006 to October 2011. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (60.1%), malfunction (37.5%) and death (2.2%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Paradigm Real-Time Insulin Infusion Pump | Pump, infusion, insulin, to be used with invasive glucose sensor | 1,389 | 0 | 0.3% |
| Pump Mmt-722nas Prdgm Ins V2 2 Sk En | Pump, infusion, insulin | 1,341 | 0 | 2.6% |
| Paradigm Real-Time Revel Insulin Infusion Pump | Pump, infusion, insulin, to be used with invasive glucose sensor | 723 | 0 | 0.6% |
| Pump Mmt-522nas Prdgm Ins V2 2 Sk En | Pump, infusion, insulin | 691 | 0 | 3.5% |
| Pump Mmt-722nab Prdgm Ins V2 2 Bl En | Pump, infusion, insulin | 588 | 0 | 2.1% |
| Pump Mmt-722nal Prdgm Ins V2 2 Cl En Pr | Pump, infusion, insulin | 569 | 0 | 2% |
| Pump Mmt-722nap Prdgm Ins V2 2 Pl En | Pump, infusion, insulin | 522 | 0 | 2.8% |
| Pump Mmt-522nal Prdgm Ins V2 2 Cl En | Pump, infusion, insulin | 419 | 0 | 0.8% |
| Rsvr Mmt-326a 10pk Prdgm 1 8ml 13l | Syringe, piston | 377 | 0 | 0.4% |
| Pump Mmt-522nab Prdgm Ins V2 2 Bl En | Pump, infusion, insulin | 288 | 0 | 1.7% |
| Pump Mmt-522nap Prdgm Ins V2 2 Pl En | Pump, infusion, insulin | 275 | 0 | 1.7% |
| Pump Mmt-715nas Prdgm Ins V2 1 Sk En | Pump, infusion, insulin | 210 | 0 | 5.1% |
| Rsvr Mmt-332a 10pk Prdgm 3cc 14l | Syringe, piston | 204 | 0 | 0.7% |
| Reservoir 1 8 Ml | Pump, infusion | 186 | 0 | 0.9% |
| Paradigm Insulin Infusion Pump | Pump, infusion, insulin | 163 | 0 | 0.4% |
| Reservoir 3cc | Pump, infusion | 132 | 0 | 3.6% |
| Reservoir 3ml | Pump, infusion | 95 | 0 | 0.8% |
| Pump Mmt-515nas Prdgm Ins V2 1 Sk En | Pump, infusion, insulin | 88 | 0 | 5.2% |
| Pump Mmt-715nal Prdgm Ins V2 1 Cl En | Pump, infusion, insulin | 75 | 0 | 3.9% |
| Paradigm Real-Time Insulin Infusion Pump Mmt-722nas | Pump, infusion, insulin, to be used with invasive glucose sensor | 27 | 8 | 1.5% |
| Paradigm Model Mmt-715 Smoke | Pump, infusion, insulin | 21 | 0 | 1.6% |
| Paradigm Real-Time Insulin Infusion Pump Mmt-522nas | Pump, infusion, insulin, to be used with invasive glucose sensor | 15 | 0 | 3% |
| Paradigm Real-Time Insulin Infusion Pump Mmt-722nab | Pump, infusion, insulin, to be used with invasive glucose sensor | 12 | 2 | 2.1% |
| Paradigm Real-Time Revel Insulin Infusion Pump Mmt-723nas | Pump, infusion, insulin, to be used with invasive glucose sensor | 10 | 49 | 0.8% |
| Paradigm Real-Time Insulin Infusion Pump Mmt-722nall | Pump, infusion, insulin, to be used with invasive glucose sensor | 8 | 1 | 0.6% |
| Reservoir 1 8ml | Pump, infusion | 7 | 0 | 0.1% |
| Paradigm Real-Time Revel Insulin Infusion Pump Mmt-723nah | Pump, infusion, insulin, to be used with invasive glucose sensor | 5 | 0 | 0.5% |
| Pump Mmt-515lnas Prdgm Ins V2 1 Sk En | Pump, infusion, insulin | 5 | 0 | 2.4% |
| Paradigm REAL-Time REVEL Insulin Infusion Pump MMT-723NAB | Pump, infusion, insulin, to be used with invasive glucose sensor | 4 | 9 | 0.8% |
| Paradigm REAL-Time REVEL Insulin Infusion Pump MMT-723NAP | Pump, infusion, insulin, to be used with invasive glucose sensor | 4 | 11 | 0.5% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LZG | Pump, infusion, insulin | 6,010 | 55.6% |
| MDS | Sensor, glucose, invasive | 3,552 | 32.9% |
| FMF | Syringe, piston | 566 | 5.2% |
| FRN | Pump, infusion | 533 | 4.9% |
| OYC | Pump, infusion, insulin, to be used with invasive glucose sensor | 109 | 1% |
| CGA | Glucose oxidase, glucose | 24 | 0.2% |
| LGZ | Warmer, thermal, infusion fluid | 3 | 0% |
| EZW | Stimulator, electrical, implantable, for incontinence | 2 | 0% |
| LGW | Stimulator, spinal-cord, totally implanted for pain relief | 2 | 0% |
| LKK | Pump, infusion, implanted, programmable | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Medtronic Puerto Rico Operations Med-Rel reports
How many FDA device reports name Medtronic Puerto Rico Operations Med-Rel as manufacturer?
10,804 reports through August 2026, 0 of them in the latest 12 months.
Which of its brands appear most often?
Paradigm Real-Time Insulin Infusion Pump (1,389), Pump Mmt-722nas Prdgm Ins V2 2 Sk En (1,341), Paradigm Real-Time Revel Insulin Infusion Pump (723), Pump Mmt-522nas Prdgm Ins V2 2 Sk En (691) and Pump Mmt-722nab Prdgm Ins V2 2 Bl En (588).
Which device types does it report on?
pump, infusion, insulin (55.6%), sensor, glucose, invasive (32.9%), syringe, piston (5.2%) and pump, infusion (4.9%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.